Patient Information Leaflet (PIL)

At Masuu Global, we specialize in creating comprehensive and compliant Patient Information Leaflets (PILs) tailored for global submissions. Our services ensure that pharmaceutical companies can effectively communicate critical information about their products to patients worldwide, promoting safe and informed medication use. Our expertise spans regulatory requirements set by major health authorities including the USFDA, EMA, Health Canada, TGA, SFDA, JFDA, and other global health authorities.

• Design, Layout and PIL:
  Designing PILs with a customer specific keyline line drawing (KLD) with using acceptable font type, font size and colours that enhances readability and accessibility.
• Review and Approval Assistance:
  Providing support throughout the review and approval process of labeling document, addressing any regulatory feedback promptly and effectively.
• Post-Market Surveillance:
  Monitoring regulatory changes and emerging safety information, ensuring that PILs are updated accordingly to reflect the lawww information.
• Lifecycle Management:
  Offering ongoing management of PIL content throughout the product lifecycle, ensuring continuous compliance and relevance.

• Expertise Across Major Markets:
  Our deep understanding of regulations from USFDA, EMA, Health Canada, TGA, SFDA, JFDA, and other global health authorities ensures your PILs meet stringent global standards.
• End-to-End Service:
  From initial drafting to regulatory submission and post-approval updates, we provide a full spectrum of PIL services.

With Masuu Global, pharmaceutical companies can ensure their Patient Information Leaflets are not only compliant but also effectively communicate vital information to patients worldwide, supporting safe and informed medication use.